HT
AKBA icon

HAP Trading’s Akebia Therapeutics AKBA Stock Holding History

HAP Trading’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,000
Closed -$17K – 1909
2022
Q1 		$17K Buy
+22,000
New +$47.1K ﹤0.01% 1627
2018
Q4 		– Sell
-12,200
Closed -$26K – 1114
2018
Q3 		$26K Hold
12,200
– – ﹤0.01% 717
2018
Q2 		$39K Buy
+12,200
New +$122K ﹤0.01% 719
2016
Q4 		– Sell
-10,000
Closed -$5K – 978
2016
Q3 		$5K Buy
+10,000
New +$85K ﹤0.01% 1031

Other funds holding AKBA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return